Biovail Seeks To Block Generic Competiton For Wellbutrin XL
Biovail Laboratories International SRL has brought a lawsuit against Watson Laboratories Inc. in order to prevent the drug maker from marketing a generic form of the anti-depressant Wellbutrin XL....To view the full article, register now.
Already a subscriber? Click here to view full article